Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib (Q51532739)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 August 2016

edit

Language	Label	Description	Also known as
English	Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib	scientific article published on 6 August 2016

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

title

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

main subject

erlotinib

1 reference

based on heuristic

inferred from title

author

Peter Meldgaard

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

author name string

Steffen Filskov Sorensen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

Christina Demuth

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

Britta Weber

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

Boe Sandahl Sorensen

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

publication date

6 August 2016

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

published in

Lung Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

volume

100

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

page(s)

77-84

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

Identifiers

DOI

10.1016/J.LUNGCAN.2016.08.001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

PubMed publication ID

27597284

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27597284

retrieved

6 April 2018

reference URL

http://europepmc.org/abstract/MED/27597284

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51532739&oldid=2276218586"